patients with objectively measurable soft tissue sarcomas , osteosarcomas , chondrosarcomas , and mesotheliomas were treated with dibromodulcitol ( dbd ) ( 180 mg/m2 p.o . days 1-10 q4 wks . ) .
C1261473
soft tissue sarcomas
C0029463
osteosarcomas